These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 31358947)

  • 1. The complete costs of genome sequencing: a microcosting study in cancer and rare diseases from a single center in the United Kingdom.
    Schwarze K; Buchanan J; Fermont JM; Dreau H; Tilley MW; Taylor JM; Antoniou P; Knight SJL; Camps C; Pentony MM; Kvikstad EM; Harris S; Popitsch N; Pagnamenta AT; Schuh A; Taylor JC; Wordsworth S
    Genet Med; 2020 Jan; 22(1):85-94. PubMed ID: 31358947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microcosting diagnostic genomic sequencing: A systematic review.
    Santos Gonzalez F; Mordaunt D; Stark Z; Dalziel K; Christodoulou J; Goranitis I
    Genet Med; 2023 Jun; 25(6):100829. PubMed ID: 36939042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health Care Costs After Genome-Wide Sequencing for Children With Rare Diseases in England and Canada.
    Weymann D; Buckell J; Fahr P; Loewen R; Ehman M; Pollard S; Friedman JM; Stockler-Ipsiroglu S; Elliott AM; Wordsworth S; Buchanan J; Regier DA
    JAMA Netw Open; 2024 Jul; 7(7):e2420842. PubMed ID: 38985473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cost of proband and trio exome and genome analysis in rare disease: A micro-costing study.
    Mordaunt DA; Gonzalez FS; Lunke S; Eggers S; Sadedin S; Chong B; Dalziel K; Stark Z; Goranitis I
    Genet Med; 2024 Apr; 26(4):101058. PubMed ID: 38164890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is the $1000 Genome as Near as We Think? A Cost Analysis of Next-Generation Sequencing.
    van Nimwegen KJ; van Soest RA; Veltman JA; Nelen MR; van der Wilt GJ; Vissers LE; Grutters JP
    Clin Chem; 2016 Nov; 62(11):1458-1464. PubMed ID: 27630156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 100 000 Genomes Project: bringing whole genome sequencing to the NHS.
    Turnbull C; Scott RH; Thomas E; Jones L; Murugaesu N; Pretty FB; Halai D; Baple E; Craig C; Hamblin A; Henderson S; Patch C; O'Neill A; Devereau A; Smith K; Martin AR; Sosinsky A; McDonagh EM; Sultana R; Mueller M; Smedley D; Toms A; Dinh L; Fowler T; Bale M; Hubbard T; Rendon A; Hill S; Caulfield MJ;
    BMJ; 2018 Apr; 361():k1687. PubMed ID: 29691228
    [No Abstract]   [Full Text] [Related]  

  • 7. Whole-genome and targeted sequencing of drug-resistant Mycobacterium tuberculosis on the iSeq100 and MiSeq: A performance, ease-of-use, and cost evaluation.
    Colman RE; Mace A; Seifert M; Hetzel J; Mshaiel H; Suresh A; Lemmer D; Engelthaler DM; Catanzaro DG; Young AG; Denkinger CM; Rodwell TC
    PLoS Med; 2019 Apr; 16(4):e1002794. PubMed ID: 31039166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost analysis of whole genome sequencing in German clinical practice.
    Plöthner M; Frank M; von der Schulenburg JG
    Eur J Health Econ; 2017 Jun; 18(5):623-633. PubMed ID: 27380512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA Genome Sequencing in Esophageal Adenocarcinoma.
    Pillai S; Gopalan V; Lam AK
    Methods Mol Biol; 2018; 1756():231-246. PubMed ID: 29600374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A microcosting study of immunogenicity and tumour necrosis factor alpha inhibitor drug level tests for therapeutic drug monitoring in clinical practice.
    Jani M; Gavan S; Chinoy H; Dixon WG; Harrison B; Moran A; Barton A; Payne K
    Rheumatology (Oxford); 2016 Dec; 55(12):2131-2137. PubMed ID: 27576368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Micro-costing diagnostics in oncology: from single-gene testing to whole- genome sequencing.
    Pasmans CTB; Tops BBJ; Steeghs EMP; Coupé VMH; Grünberg K; de Jong EK; Schuuring EMD; Willems SM; Ligtenberg MJL; Retèl VP; van Snellenberg H; de Bruijn E; Cuppen E; Frederix GWJ
    Expert Rev Pharmacoecon Outcomes Res; 2021 Jun; 21(3):413-414. PubMed ID: 33852815
    [No Abstract]   [Full Text] [Related]  

  • 12. Sequencing projects will screen 200,000 newborns for disease.
    Kaiser J
    Science; 2022 Dec; 378(6625):1159. PubMed ID: 36520905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integration of whole genome sequencing into a healthcare setting: high diagnostic rates across multiple clinical entities in 3219 rare disease patients.
    Stranneheim H; Lagerstedt-Robinson K; Magnusson M; Kvarnung M; Nilsson D; Lesko N; Engvall M; Anderlid BM; Arnell H; Johansson CB; Barbaro M; Björck E; Bruhn H; Eisfeldt J; Freyer C; Grigelioniene G; Gustavsson P; Hammarsjö A; Hellström-Pigg M; Iwarsson E; Jemt A; Laaksonen M; Enoksson SL; Malmgren H; Naess K; Nordenskjöld M; Oscarson M; Pettersson M; Rasi C; Rosenbaum A; Sahlin E; Sardh E; Stödberg T; Tesi B; Tham E; Thonberg H; Töhönen V; von Döbeln U; Vassiliou D; Vonlanthen S; Wikström AC; Wincent J; Winqvist O; Wredenberg A; Ygberg S; Zetterström RH; Marits P; Soller MJ; Nordgren A; Wirta V; Lindstrand A; Wedell A
    Genome Med; 2021 Mar; 13(1):40. PubMed ID: 33726816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost Analyses of Genomic Sequencing: Lessons Learned from the MedSeq Project.
    Christensen KD; Phillips KA; Green RC; Dukhovny D
    Value Health; 2018 Sep; 21(9):1054-1061. PubMed ID: 30224109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating the costs of genomic sequencing in cancer control.
    Gordon LG; White NM; Elliott TM; Nones K; Beckhouse AG; Rodriguez-Acevedo AJ; Webb PM; Lee XJ; Graves N; Schofield DJ
    BMC Health Serv Res; 2020 Jun; 20(1):492. PubMed ID: 32493298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-genome sequencing of patients with rare diseases in a national health system.
    Turro E; Astle WJ; Megy K; Gräf S; Greene D; Shamardina O; Allen HL; Sanchis-Juan A; Frontini M; Thys C; Stephens J; Mapeta R; Burren OS; Downes K; Haimel M; Tuna S; Deevi SVV; Aitman TJ; Bennett DL; Calleja P; Carss K; Caulfield MJ; Chinnery PF; Dixon PH; Gale DP; James R; Koziell A; Laffan MA; Levine AP; Maher ER; Markus HS; Morales J; Morrell NW; Mumford AD; Ormondroyd E; Rankin S; Rendon A; Richardson S; Roberts I; Roy NBA; Saleem MA; Smith KGC; Stark H; Tan RYY; Themistocleous AC; Thrasher AJ; Watkins H; Webster AR; Wilkins MR; Williamson C; Whitworth J; Humphray S; Bentley DR; ; Kingston N; Walker N; Bradley JR; Ashford S; Penkett CJ; Freson K; Stirrups KE; Raymond FL; Ouwehand WH
    Nature; 2020 Jul; 583(7814):96-102. PubMed ID: 32581362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical whole-genome sequencing in cancer diagnosis.
    Hou YC; Neidich JA; Duncavage EJ; Spencer DH; Schroeder MC
    Hum Mutat; 2022 Nov; 43(11):1519-1530. PubMed ID: 35471774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-genome sequencing as a first-tier diagnostic framework for rare genetic diseases.
    Nisar H; Wajid B; Shahid S; Anwar F; Wajid I; Khatoon A; Sattar MU; Sadaf S
    Exp Biol Med (Maywood); 2021 Dec; 246(24):2610-2617. PubMed ID: 34521224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A streamlined workflow for single-cells genome-wide copy-number profiling by low-pass sequencing of LM-PCR whole-genome amplification products.
    Ferrarini A; Forcato C; Buson G; Tononi P; Del Monaco V; Terracciano M; Bolognesi C; Fontana F; Medoro G; Neves R; Möhlendick B; Rihawi K; Ardizzoni A; Sumanasuriya S; Flohr P; Lambros M; de Bono J; Stoecklein NH; Manaresi N
    PLoS One; 2018; 13(3):e0193689. PubMed ID: 29494651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shortening the diagnostic odyssey-the impact of whole genome sequencing in the NHS.
    Chinnery PF
    BMJ; 2021 Nov; 375():n2683. PubMed ID: 34732384
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.